Blast Crisis of CML After TKI Discontinuation in a Patient With Previous Stable Deep Molecular Response: Is It Safe to Stop?

Authors :: Anastasia Athanasiadou
Achilles Anagnostopoulos
Maria Papathanasiou
Apostolia Papalexandri
Eirini Baldoumi
Christos Demosthenous
Riad Saloum
Maria-Georgia Koutra
Chrysaygi Lalayanni
Panagiota Zerva
Tasoula Touloumenidou
Source :: HemaSphere, Vol 2, Iss 6 (2018), HemaSphere
Publication Year :: 2018
Publisher :: Wolters Kluwer, 2018.

Subjects :: medicine.medical_specialty
Blast Crisis
business.industry
lcsh:RC633-647.5
MEDLINE
Case Report
Hematology
lcsh:Diseases of the blood and blood-forming organs
Discontinuation
03 medical and health sciences
0302 clinical medicine
030220 oncology & carcinogenesis
Molecular Response
medicine
Intensive care medicine
business
030215 immunology

Tools